Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy
Status:
Completed
Trial end date:
2020-03-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether once-nightly FT218 is safe and effective
for the treatment of excessive daytime sleepiness and cataplexy in subjects with narcolepsy.